Mahendiran Dharmasivam

Papers

Total Citations

H-Index

About

Dr. Mahendiran Dharmasivam is a leading voice at the intersection of artificial intelligence and pharmaceutical science, with a primary research focus on AI-driven drug discovery platforms and their real-world efficacy. His major contributions lie in critically evaluating the rapidly evolving landscape of computational drug development, particularly through his landmark 2025 study, "Leading artificial intelligence–driven drug discovery platforms: 2025 landscape and global outlook," which has already garnered 12 citations for its comprehensive analysis of emerging technologies. In his equally provocative work, "Artificial intelligence–assisted drug discovery in 2025: Faster, but is it better? The robots are coming, look out!"—which has earned 1 citation—Dharmasivam challenges the field to move beyond speed metrics and interrogate the qualitative improvements AI brings to therapeutic development. His research is notable for its balanced perspective, celebrating innovation while demanding rigorous validation, making him a trusted commentator in a field often dominated by hype. For students and researchers, Dharmasivam’s work offers a critical roadmap for navigating the promises and pitfalls of AI in drug discovery.